Abstract
It has been shown that the establishment of urinary tract infection by Escherichia coli is dependent on attachment of the bacteria to epithelial cells1–4. The attachment involves specific epithelial cell receptors, which have been characterized as glycolipids5–10. Reversible binding to cell-surface mannosides may also be important4,11–13. This suggests an approach to the treatment of infections—that of blocking bacterial attachment with cell membrane receptor analogues. Using E. coli mutants lacking one or other of the two binding specificities (glycolipid and mannose), we show here that glycolipid analogues can block in vitro adhesion and in vivo urinary tract infection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Svanborg-Edén, C. et al. Ciba Fdn Symp. 80, 161–187 (1981).
Svanborg-Edén, C. et al. in Bacterial Vaccines (eds Robbins, J. B., Hill, J. C. & Sadoff, C.) 113–131 (Thieme-Stratton, New York, 1982).
Svanborg-Edén, C., Eriksson, B. & Hanson, L. A. Infect. Immun. 18, 767–774 (1977).
Hughes, R. C. & Sharon, N. Trends biochem. Sci. 3, 275–278 (1978).
Leffler, H. & Svanborg Edén, C. FEMS microbiol. Lett. 8, 127–134 (1980).
Leffler, H. & Svanborg-Edén, C. Infect. Immun. 34, 920–929 (1982).
Leffler, H. et al. Scand. J. infect. Dis. (in the press).
Källenius, G. et al. Lancet ii, 604–606 (1981).
Källenius, G. et al. Lancet ii, 1369–1372 (1981).
Väisänen, V. et al. Lancet ii, 1366–1369 (1981).
Salit, I. E. & Gotschlich, E. C. J. exp. Med. 146, 1169–1181 (1977).
Beachey, E. H. J. infect. Dis. 143, 325–345 (1981).
Ørskov, I. Ørskov, F. & Birch-Andersen, A. Infect. Immun. 27, 657–666 (1980).
Hull, R., Falkow, S., Leffler, H., Svanborg-Edén, C. (in preparation).
Selander, R. K. & Levin, B. R. Science 210, 545–547 (1980).
Caugant, D. A., Levin, B. R. & Selander, R. K. Genetics 98, 467–490 (1981).
Lidin-Janson, G., Falsen, E., Jodal, U., Kaijser, B. & Lincoln, K. J. med. Microbiol. 10, 299–308 (1977).
Olling, S. et al. Infection 1, 23–28 (1973).
Wiegandt, H. & Baschang, G. Z. Naturforsch. 206, 164–166 (1965).
Aronson, M. et al. J. infect. Dis. 139, 329–332 (1979).
Duguid, J. P. & Old, D. C. in Bacterial Adherence (ed. Beachey, E. H.) 185–217 (Chapman & Hall, London, 1980).
Holmgren, J. Nature 292, 413–417 (1981).
Falk, K.-E., Jovall, P.-Å, Winyard, P. Acta chem. scand. (in the press).
Colton, T. Statistics in Medicine, 35 (LittleBrown, Boston, 1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edén, C., Freter, R., Hagberg, L. et al. Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature 298, 560–562 (1982). https://doi.org/10.1038/298560a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/298560a0
This article is cited by
-
Immunomodulation therapy offers new molecular strategies to treat UTI
Nature Reviews Urology (2022)
-
Malodorous biogenic amines in Escherichia coli-caused urinary tract infections in women—a metabolomics approach
Scientific Reports (2020)
-
Determinants encoding fimbriae type 1 in fecal Escherichia coli are associated with increased frequency of bacteriocinogeny
BMC Microbiology (2015)
-
Bacteriocin-encoding genes and ExPEC virulence determinants are associated in human fecal Escherichia coli strains
BMC Microbiology (2014)
-
Urinary tract infection in pregnant women: Old dogmas and current concepts regarding pathogenesis
Current Infectious Disease Reports (2002)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
